Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) EPS (Weighted Average and Diluted) (2019 - 2025)

Orthopediatrics has reported EPS (Weighted Average and Diluted) over the past 7 years, most recently at -$0.43 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.43 for Q4 2025, up 38.57% from a year ago — trailing twelve months through Dec 2025 was -$1.69 (down 3.05% YoY), and the annual figure for FY2025 was -$1.69, down 3.05%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.43 at Orthopediatrics, up from -$0.5 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for KIDS hit a ceiling of $0.87 in Q3 2022 and a floor of -$0.7 in Q4 2024.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.3 (2023), compared with a mean of -$0.25.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 890.91% in 2022, while the deepest fall reached 10001.74% in 2022.
  • Orthopediatrics' EPS (Weighted Average and Diluted) stood at $0.0 in 2021, then plummeted by 10001.74% to -$0.37 in 2022, then increased by 21.62% to -$0.29 in 2023, then crashed by 141.38% to -$0.7 in 2024, then soared by 38.57% to -$0.43 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.43 (Q4 2025), -$0.5 (Q3 2025), and -$0.3 (Q2 2025) per Business Quant data.